Published on 5 May 2024 on Simply Wall St. via Yahoo Finance
Investors in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) had a good week, as its shares rose 7.7% to close at US$31.57 following the release of its first-quarter results. It looks like a credible result overall - although revenues of US$155m were in line with what the analysts predicted, Harmony Biosciences Holdings surprised by delivering a statutory profit of US$0.67 per share, a notable 11% above expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
View our latest analysis for Harmony Biosciences Holdings
earnings-and-revenue-growth